Bedside prediction of mortality from bacteremic sepsis: A dynamic analysis of ICU patients

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 2, 1996, Pages 684-693

  Pittet, Didier ^a   Thiévent, Bernard ^b   Wenzel, Richard P ^b   Li, Ning ^b   Auckenthaler, Raymond ^b   Suter, Peter M ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BLOOD CULTURE; CRITICAL ILLNESS; DISEASE SEVERITY; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; TREATMENT PLANNING;

EID: 0030051905     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.2.8564118     Document Type: Article

References (44)

1. Bone, R. C., C. J. Fisher, Jr., T. P. Clemmer, G. J. Slotman, C. A. Metz, and R. Balk. 1989. Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit. Care Med. 17:389-393.
2. Ziegler, E. J., C. J. Fisher, Jr., C. L. Sprung, R. C. Straube, J. C. Sadoff, G. E. Foulke, C. H. Wortel, M. P. Fink, R. P. Dellinger, N. N. H. Teng, I. E. Allen, H. J. Berger, G. L. Knatterud, A. F. LoBuglio, and C. R. Smith. 1991. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: a randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 324:429-436.
3. Greenman, R. L., R. M. H. Schein, M. A. Martin, R. P. Wenzel, N. R. MacIntyre, G. Emmanuel, H. Chmel, R. B. Kohler, M. McCarthy, J. Plouffe, and J. A. Russell. 1991. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. J.A.M.A. 266:1097-1102.
4. Fisher, C. J., Jr., G. J. Slotman, S. M. Opal, J. P. Pribble, R. C. Bone, G. Emmanuel, D. Ng, D. C. Bloedow, and M. Catalano. 1994. Initial elevation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-1RA Sepsis Syndrome Study Group. Crit. Care Med. 22:12-21.
5. Weinstein, M. P., J. R. Murphy, L. B. Reller, and K. A. Lichtenstein. 1983. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev. Infect. Dis. 5:54-70.
6. Gatell, J. M., A. Trilla, X. Latorre, M. Almela, J. Mensa, A. Moreno, J. M. Miro, J. A. Martinez, M. T. J. De Anta, E. Soriano, and J. Garcia San Miguel. 1988. Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. Rev. Infect. Dis. 10:203-210.
7. Wenzel, R. P. 1988. The mortality of hospital-acquired bloodstream infections: need for a new vital statistic? Int. J. Epidemiol. 17:225-227.
8. Pittet, D. 1993. Nosocomial bloodstream infections. In R. P. Wenzel, editor. Prevention and control of nosocomial infections, 2nd ed. Williams and Wilkins, Baltimore. 512.
9. McCabe, W. R., and G. G. Jackson. 1962. Gram-negative bacteremia. II. Clinical laboratory and therapeutic observations. Arch. Intern. Med. 110:856-864.
10. Pittet, D., B. Thiévent, R. P. Wenzel, N. Li, G. Gurman, and P. M. Suter. 1993. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med. 19:265-272.
11. Pittet, D., D. Tarara, and R. P. Wenzel. 1994. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. J.A.M.A. 271:1598-1601.
12. Bryan, C. S., K. L. Reynolds, and E. R. Brenner. 1983. Analysis of 1186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev. Infect. Dis. 5:629-638.
13. Wenzel, R. P. 1992. Anti-endotoxin monoclonal antibodies - a second look. N. Engl. J. Med. 326:1151-1153.
14. Tracey, K. J., Y. Fong, and D. G. Hesse. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662-665.
15. Pittet, D., L. A. Herwaldt, and R. M. Massanari. 1992. The Intensive Care Unit. In P. S. Brachman and J. V. Bennett, editors. Hospital Infections, 3rd ed. Little, Brown, Boston, MA. 405.
16. Knaus, W. A., E. A. Draper, D. P. Wagner, and J. E. Zimmerman. 1985. APACHE II: a severity of disease classification system. Crit. Care Med. 13:818.
17. Montgomery, A. B., M. A. Stager, J. Carrico, and L. D. Hudson. 1985. Causes of mortality in patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132:485-489.
18. Dominguez de Villota, E., A. Algora, A. Rubio, M. Roig, J. M. Mosquera, P. Galdos, and V. Diez-Balda. 1983. Septicemia in a medical intensive care unit: clinical, biochemical and microbiological data of 109 cases. Intensive Care Med. 9:109-115.
19. Miller, P. J., and R. P. Wenzel. 1987. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J. Infect. Dis. 156:471-477.
20. Roberts, F. J., I. W. Geere, and A. Coldman. 1991. A three-year study of positive blood cultures, with emphasis on prognosis. Rev. Infect. Dis. 13:34-46.
21. Pittet, D., N. Li, and R. P. Wenzel. 1993. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur. J. Clin. Microbiol. Infect. Dis. 12:813-819.
22. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864-874.
23. Baker, C., L. Oppenheimer, B. Stephens, F. R. Lewis, and D. D. Trunkey. 1980. Epidemiology of trauma deaths. Am. J. Surg. 140:144-150.
24. Stanford, J. P. 1990. Guide to antimicrobial therapy. Antimicrobial Therapy, Inc., Dallas, TX.
25. Weinstein, M. P., and L. B. Reller. 1984. Clinical importance of "breakthrough" bacteremia. Am. J. Med. 76:175-180.
26. Murray, J. F., M. A. Matthay, J. M. Luce, and M. R. Flick. 1988. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:720-723.
27. Knaus, W. A., F. E. Harrell, C. J. Fisher, D. P. Wagner, S. M. Opal, J. C. Sadoff, E. A. Draper, C. A. Walawander, K. Conboy, and T. H. Grasela. 1993. The clinical evaluation of new drugs for sepsis: a prospective study design based on survival analysis. J.A.M.A. 270: 1233-1241.
28. Goodman, L. A., and W. H. Kruskal. 1979. Measures of association for cross-classifications. Springer-Verlag NY Inc., New York.
29. Efron, B., and R. J. Tibshirani. 1993. An introduction to the bootstrap. Chapman & Hall, New York.
30. Le Gall, J. R., S. Lemeshow, and F. Saulnier. 1993. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. J.A.M.A. 270:2957-2963.
31. Lemeshow, S., D. Teres, J. Klar, J. S. Avrunin, S. H. Gehlbach, and J. Rapoport. 1993. Mortality probability models (MPM II) based on an international cohort of intensive care unit patients. J.A.M.A. 270:2478-2486.
32. Chang, R. W. S., S. Jacobs, and B. Lee. 1988. Predicting outcome among intensive care unit patients using computerised trend analysis of daily APACHE II scores corrected for organ system failure. Intensive Care Med. 14:558-566.
33. Larvin, M., and M. J. McMahon. 1989. APACHE II score for assessment and monitoring for acute pancreatitis. Lancet ii: 201-204.
34. Sawyer, R. G., L. K. Rosendorf, and R. B. Adams. 1992. Peritonitis into the 1990's: changing pathogens and changing strategies in the critically ill. Am. Surg. 58:82-87.
35. Schedel, I., U. Dreikhusen, and B. Nentwig. 1991. Treatment of gram negative septic shock with a polyclonal immunoglobulin: a prospective randomised clinical trial. Crit. Care Med. 19:1104-1112.
36. Knaus, W. A., D. P. Wagner, E. A. Draper, J. E. Zimmerman, M. Bergner, P. G. Bastos, C. A. Sirio, D. J. Murphy, T. Lotring, A. Damanio, and F. E. Harrell. 1991. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100:1619-1636.
37. Lemeshow, S., J. Klar, D. Teres, J. S. Avrunin, S. H. Gehlbach, J. Rapoport, and M. Rué. 1994. Mortality probability models for patients in the intensive care unit for 48 or 72 h: a prospective, multicenter study. Crit. Care Med. 22:1351-1358.
38. Wagner, D. P., W. A. Knaus, F. E. Harell, J. E. Zimmermann, and C. Watts. 1994. Daily prognostic estimates for critically ill adults in intensive care units: results from a prospective, multicenter, inception cohort analysis. Crit. Care Med. 22:1359-1372.
39. Le Gall, J. R., S. Lemeshow, G. Leleu, J. Klar, J. Huillard, M. Rué, D. Teres, and A. Artigas. 1995. Customized probability models for early severe sepsis in adult intensive care patients. J.A.M.A. 273: 644-650.
40. Craven, D. E., L. M. Kunches, and D. A. Lichtenberg. 1988. Nosocomial infection and fatality in medical surgical intensive care unit patients. Arch. Intern. Med. 148:1161.
41. Clemmer, T. P., C. J. Fisher, Jr., R. C. Bone, G. J. Slotman, C. A. Metz, and F. Thomas. 1992. Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit. Care Med. 20:1395-1401.
42. Balk, R. A., and J. E. Parillo. 1992. Prognositic factors in sepsis: the cold facts. Crit. Care Med. 20:1373-1374.
43. Herbert, P. C., A. J. Drummond, J. Singer, G. R. Bernard, and J. A. Russell. 1993. A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 104: 230-235.
44. Rangel-Frausto, M. S., D. Pittet, M. Costigan, T. Hwang, C. Davis, and R. P. Wenzel. 1995. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. J.A.M.A. 273:117-123.